{"id":"https://openalex.org/W2155106983","doi":"https://doi.org/10.1185/030079905x65439","title":"Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial","display_name":"Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial","alternate_titles":[],"publication_year":2005,"publication_date":"2005-09-21","ids":{"openalex":"https://openalex.org/W2155106983","doi":"https://doi.org/10.1185/030079905x65439","mag":"2155106983","pmid":"https://pubmed.ncbi.nlm.nih.gov/16238909"},"language":"en","primary_location":{"id":"doi:10.1185/030079905x65439","doi":"https://doi.org/10.1185/030079905x65439","is_oa":false,"landing_page_url":"https://doi.org/10.1185/030079905x65439","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2155106983"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110033646","display_name":"C Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146742","display_name":"Community Research Initiative","ror":"https://ror.org/04bekvf09","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210146742"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"C. Cohen","raw_affiliation_strings":["Community Research Initiative of New England, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community Research Initiative of New England, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210146742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025983288","display_name":"Leopoldo Nieto\u2010Cisneros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164915025","display_name":"Mexican Social Security Institute","ror":"https://ror.org/03xddgg98","country_code":"MX","type":"government","lineage":["https://openalex.org/I164915025"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"L. Nieto-Cisneros","raw_affiliation_strings":["Hospital Gabriel Mancera IMSS, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Gabriel Mancera IMSS, Mexico City, Mexico","institution_ids":["https://openalex.org/I164915025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053198362","display_name":"Carlos Zala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106546","display_name":"Fundaci\u00f3n Hu\u00e9sped","ror":"https://ror.org/01p47g940","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210106546"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"C. Zala","raw_affiliation_strings":["Fundacion Huesped, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundacion Huesped, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210106546"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024912798","display_name":"W. Jeffrey Fessel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I4210122929","display_name":"Kaiser Permanente San Francisco Medical Center","ror":"https://ror.org/02fxsj090","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210122929"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. J. Fessel","raw_affiliation_strings":["Kaiser Permanente Medical Center, San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente Medical Center, San Francisco, California, USA","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4210122929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084032137","display_name":"Juan Gonz\u00e1lez\u2010Garc\u00eda","orcid":"https://orcid.org/0000-0002-3652-002X","observed_orcids":["https://orcid.org/0000-0002-3652-002X"]},"institutions":[{"id":"https://openalex.org/I2800562746","display_name":"Hospital Universitario La Paz","ror":"https://ror.org/01s1q0w69","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Gonzalez-Garcia","raw_affiliation_strings":["Hospital La Paz, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital La Paz, Madrid, Spain","institution_ids":["https://openalex.org/I2800562746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101868349","display_name":"Aleksandra K. G\u0142adysz","orcid":"https://orcid.org/0009-0001-8901-7081","observed_orcids":["https://orcid.org/0009-0001-8901-7081"]},"institutions":[{"id":"https://openalex.org/I385303915","display_name":"Wroclaw Medical University","ror":"https://ror.org/01qpw1b93","country_code":"PL","type":"education","lineage":["https://openalex.org/I385303915"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"A. Gladysz","raw_affiliation_strings":["Wroclaw Medical University, Wroclaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wroclaw Medical University, Wroclaw, Poland","institution_ids":["https://openalex.org/I385303915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087018486","display_name":"Rachel T. McGovern","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. McGovern","raw_affiliation_strings":["Bristol-Myers Squibb, Wallingford, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Wallingford, Connecticut, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038118445","display_name":"Edward C. Adler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Adler","raw_affiliation_strings":["Bristol-Myers Squibb, Pennington, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071859557","display_name":"Colin McLaren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. McLaren","raw_affiliation_strings":["Bristol-Myers Squibb, Wallingford, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Wallingford, Connecticut, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the BMS, AI424\u2010043 Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"on behalf of the BMS, AI424\u2010043 Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5110033646"],"corresponding_institution_ids":["https://openalex.org/I4210146742"],"apc_list":null,"apc_paid":null,"fwci":6.61,"has_fulltext":false,"cited_by_count":95,"citation_normalized_percentile":{"value":0.97215554,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"21","issue":"10","first_page":"1683","last_page":"1692"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atazanavir","display_name":"atazanavir","score":0.9829999804496765},{"id":"https://openalex.org/keywords/lopinavir-ritonavir","display_name":"lopinavir/ritonavir","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hiv-rna-suppression","display_name":"HIV RNA suppression","score":0.6880000233650208},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.6439999938011169},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8330000042915344},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8539999723434448},{"id":"https://openalex.org/keywords/antiviral-efficacy","display_name":"antiviral efficacy","score":0.6069999933242798},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.6940000057220459},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.7369999885559082},{"id":"https://openalex.org/keywords/hiv-treatment-regimens","display_name":"HIV treatment regimens","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C2777182164","wikidata":"https://www.wikidata.org/wiki/Q422585","display_name":"Lopinavir","level":5,"score":0.9592885971069336},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.9518078565597534},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.9303308129310608},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8842559456825256},{"id":"https://openalex.org/C2781392899","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Lopinavir/ritonavir","level":5,"score":0.7431197166442871},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5606215000152588},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5344333648681641},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5211546421051025},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.48975181579589844},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4674587845802307},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4629005193710327},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.3228186368942261},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2521681785583496},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.20315751433372498},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.19054636359214783},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.08528834581375122}],"mesh":[{"descriptor_ui":"D000069446","descriptor_name":"Atazanavir Sulfate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061466","descriptor_name":"Lopinavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/030079905x65439","doi":"https://doi.org/10.1185/030079905x65439","is_oa":false,"landing_page_url":"https://doi.org/10.1185/030079905x65439","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:16238909","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16238909","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W197130036","https://openalex.org/W1977509185","https://openalex.org/W1977726608","https://openalex.org/W1977784059","https://openalex.org/W1979625649","https://openalex.org/W1991485152","https://openalex.org/W1993508860","https://openalex.org/W2001169776","https://openalex.org/W2003808400","https://openalex.org/W2007061978","https://openalex.org/W2008383946","https://openalex.org/W2025582221","https://openalex.org/W2043390279","https://openalex.org/W2044237989","https://openalex.org/W2053298654","https://openalex.org/W2056779298","https://openalex.org/W2060825301","https://openalex.org/W2072845217","https://openalex.org/W2075668518","https://openalex.org/W2088008322","https://openalex.org/W2118861418","https://openalex.org/W2136385005","https://openalex.org/W2138125850","https://openalex.org/W2162683875","https://openalex.org/W2164099498","https://openalex.org/W2318289184","https://openalex.org/W2322811126","https://openalex.org/W2324473093","https://openalex.org/W2335346509","https://openalex.org/W2339057709","https://openalex.org/W2396089759","https://openalex.org/W4238251256","https://openalex.org/W4249825849","https://openalex.org/W4285719527","https://openalex.org/W4296391115"],"related_works":["https://openalex.org/W2076420181","https://openalex.org/W2144518502","https://openalex.org/W2088008322","https://openalex.org/W1988101744","https://openalex.org/W2049969210","https://openalex.org/W1529006453","https://openalex.org/W2045131275","https://openalex.org/W2001169776","https://openalex.org/W2045813763","https://openalex.org/W1976641979"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"compare":[2],"change":[3,184],"from":[4],"baseline":[5,171,175],"in":[6,16,67,102,107,132,139,166,181,187,203,221],"HIV":[7,73,108],"RNA":[8,74,109],"and":[9,59,80,148,193,198,207,234,275],"fasting":[10,188,194],"low-density":[11],"lipoprotein":[12],"(LDL)":[13],"cholesterol":[14],"levels":[15],"protease":[17],"inhibitor":[18],"(PI)-experienced":[19],"patients":[20,68,91,216,255,269],"receiving":[21],"unboosted":[22,111],"atazanavir":[23,112,179,223],"400":[24,30],"mg":[25,31,36],"once":[26],"daily":[27],"versus":[28],"lopinavir":[29],"boosted":[32],"with":[33,39,69,251,256],"ritonavir":[34],"100":[35],"twice":[37],"daily,":[38],"two":[40],"nucleoside":[41],"reverse":[42],"transcriptase":[43],"inhibitors":[44],"(NRTIs).":[45],"Secondary":[46,124],"objectives":[47],"included":[48],"virologic":[49,266],"response,":[50],"CD4":[51,81],"cell":[52],"count":[53,82],"changes,":[54,57],"other":[55],"lipid":[56,273],"safety,":[58],"tolerability.":[60],"METHODS:":[61],"Randomized,":[62],"open-label,":[63],"multinational,":[64],"48-week":[65],"study":[66],"one":[70],"PI-regimen":[71],"failure,":[72],">":[75,83],"or":[76,84,185],"=":[77,85],"1000":[78],"copies/mL,":[79,117],"50":[86],"cells/mm3.":[87],"RESULTS:":[88],"Three":[89],"hundred":[90],"were":[92,136,146,152,163,217,232],"randomized;":[93],"290":[94],"treated":[95],"(144":[96],"atazanavir,":[97],"146":[98],"lopinavir/ritonavir).":[99,229],"Lopinavir/ritonavir":[100],"resulted":[101,180,202],"a":[103,271],"significantly":[104],"greater":[105,246],"reduction":[106],"than":[110],"(-2.02":[113],"vs":[114,226],"-1.59":[115],"log10":[116],"p":[118],"<":[119,210],"0.001)":[120],"at":[121,158,260],"week":[122,177],"48.":[123],"efficacy":[125,133],"endpoints":[126],"also":[127,137],"favored":[128],"lopinavir/ritonavir;":[129],"the":[130,222],"differences":[131],"between":[134],"regimens":[135,162,231,263],"observed":[138,250],"secondary":[140],"analyses":[141],"comparing":[142],"those":[143,149,254],"subjects":[144,150,167],"who":[145,151,168],"susceptible":[147],"resistant":[153],"to":[154,176],"their":[155],"respective":[156],"PIs":[157],"baseline.":[159],"However,":[160],"both":[161,239,262],"equally":[164],"effective":[165],"had":[169],"no":[170,183,257],"NRTI":[172,258],"mutations.":[173],"From":[174],"48,":[178],"either":[182],"decreases":[186],"LDL":[189],"cholesterol,":[190,192],"total":[191],"triglycerides":[195],"(-6%,":[196],"-2%,":[197],"+1%),":[199],"whereas":[200],"lopinavir/ritonavir":[201],"increases":[204],"(+3%,":[205],"+12%,":[206],"+53%)":[208],"(p":[209],"0.05,":[211],"all":[212],"between-treatment":[213],"comparisons).":[214],"Fewer":[215],"administered":[218],"lipid-lowering":[219,279],"therapy":[220],"arm":[224],"(6%":[225],"20%":[227],"for":[228],"Both":[230],"safe":[233],"well":[235],"tolerated.":[236],"CONCLUSIONS:":[237],"While":[238],"treatments":[240],"demonstrated":[241,264,270],"good":[242],"antiviral":[243,247],"efficacy,":[244],"relatively":[245],"suppression":[248],"was":[249],"lopinavir/ritonavir.":[252],"In":[253],"mutations":[259],"baseline,":[261],"comparable":[265],"suppression.":[267],"Atazanavir-treated":[268],"superior":[272],"profile":[274],"required":[276],"less":[277],"frequent":[278],"treatment.":[280]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2155106983","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
